Table of Contents

2019-2024 Global Rare Disease Diagnostics Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rare Disease Diagnostics Market Size 2014-2024
2.1.2 Rare Disease Diagnostics Market Size CAGR by Region
2.2 Rare Disease Diagnostics Segment by Type
2.2.1 Hematology
2.2.2 Oncology
2.3 Rare Disease Diagnostics Market Size by Type
2.3.1 Global Rare Disease Diagnostics Market Size Market Share by Type (2014-2019)
2.3.2 Global Rare Disease Diagnostics Market Size Growth Rate by Type (2014-2019)
2.4 Rare Disease Diagnostics Segment by Application
2.4.1 Hospital Laboratories
2.4.2 Diagnostic Laboratories
2.4.3 Genetic Testing Laboratories
2.4.4 Cancer Research Laboratories
2.4.5 Others
2.5 Rare Disease Diagnostics Market Size by Application
2.5.1 Global Rare Disease Diagnostics Market Size Market Share by Application (2014-2019)
2.5.2 Global Rare Disease Diagnostics Market Size Growth Rate by Application (2014-2019)

3 Global Rare Disease Diagnostics by Players
3.1 Global Rare Disease Diagnostics Market Size Market Share by Players
3.1.1 Global Rare Disease Diagnostics Market Size by Players (2017-2019)
3.1.2 Global Rare Disease Diagnostics Market Size Market Share by Players (2017-2019)
3.2 Global Rare Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers and Acquisitions, Expansion

4 Rare Disease Diagnostics by Regions
4.1 Rare Disease Diagnostics Market Size by Regions
4.2 Americas Rare Disease Diagnostics Market Size Growth
4.3 APAC Rare Disease Diagnostics Market Size Growth
4.4 Europe Rare Disease Diagnostics Market Size Growth
4.5 Middle East and Africa Rare Disease Diagnostics Market Size Growth

5 Americas
5.1 Americas Rare Disease Diagnostics Market Size by Countries
5.2 Americas Rare Disease Diagnostics Market Size by Type
5.3 Americas Rare Disease Diagnostics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Rare Disease Diagnostics Market Size by Countries
6.2 APAC Rare Disease Diagnostics Market Size by Type
6.3 APAC Rare Disease Diagnostics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Rare Disease Diagnostics by Countries
7.2 Europe Rare Disease Diagnostics Market Size by Type
7.3 Europe Rare Disease Diagnostics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Rare Disease Diagnostics by Countries
8.2 Middle East and Africa Rare Disease Diagnostics Market Size by Type
8.3 Middle East and Africa Rare Disease Diagnostics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Rare Disease Diagnostics Market Forecast
10.1 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)
10.2 Global Rare Disease Diagnostics Forecast by Regions
10.2.1 Global Rare Disease Diagnostics Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East and Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East and Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Rare Disease Diagnostics Forecast by Type
10.8 Global Rare Disease Diagnostics Forecast by Application

11 Key Players Analysis
11.1 Retrophin
11.1.1 Company Details
11.1.2 Rare Disease Diagnostics Product Offered
11.1.3 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Retrophin News
11.2 3billion
11.2.1 Company Details
11.2.2 Rare Disease Diagnostics Product Offered
11.2.3 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 3billion News
11.3 23andMe
11.3.1 Company Details
11.3.2 Rare Disease Diagnostics Product Offered
11.3.3 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 23andMe News
11.4 QIAGEN
11.4.1 Company Details
11.4.2 Rare Disease Diagnostics Product Offered
11.4.3 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 QIAGEN News
11.5 Illumina
11.5.1 Company Details
11.5.2 Rare Disease Diagnostics Product Offered
11.5.3 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Illumina News
11.6 PerkinElmer
11.6.1 Company Details
11.6.2 Rare Disease Diagnostics Product Offered
11.6.3 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 PerkinElmer News
11.7 Strand Life Sciences
11.7.1 Company Details
11.7.2 Rare Disease Diagnostics Product Offered
11.7.3 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Strand Life Sciences News
...

12 Research Findings and Conclusion